Inovo Research
Investment Thesis
Inovo (Inovo Venture Partners) is a Warsaw-based venture capital firm, founded in 2011, that backs ambitious founders building large-market, category-defining companies out of Central and Eastern Europe (CEE) and the diaspora. The firm's stated philosophy is explicitly founder-centric: it prioritizes founder and company interests above internal fund considerations, favors "ambitious projects with 100x return potential" over safer, lower-return bets, and grounds decisions in market data and benchmarks rather than intuition. Inovo markets itself as "the most helpful VC on board," emphasizing hands-on support (talent, follow-on fundraising, customer introductions, advisory network) over passive capital.
Sector Focus
Inovo is multi-vertical but has clear areas of depth, visible across a 50+ company portfolio:
- Developer Tools & Infrastructure (Pythagora, Quesma, Archbee, Spacelift, Nodeshift)
- AI / Data Science (Ingenix.ai, Pathway, Quantia, Gralio.ai, mysite.ai, Quantum Boost, Splx.ai)
- Healthcare / Digital Health (Infermedica, Embla, Mindly, Evidose, Pupilmed, Jutromedical, Index Health)
- Fintech (Handwave, Symmetrical, Fiat Republic)
- EdTech (Preply, LiveKid, Prepia, SmartSchool, Bloomcoding)
- SaaS-enabled marketplaces and B2C/B2B2C/B2B Enterprise more broadly (Booksy, Tidio, Zowie, Packhelp)
Team-level focus areas reinforce this: partners individually own developer tools/deeptech/infrastructure, data science/AI, healthcare, and B2B2C/SME, suggesting sector coverage is distributed across the partnership rather than generalist.
Stage Focus
Pre-Seed and Seed is the core of the strategy, with occasional Series A. The firm describes itself as aiming to be the first institutional check for founders, though the portfolio includes several post-seed and Series A follow-on positions (LiveKid, Embla, Eyerim, Tidio, Infermedica at Series A; Preply and Packhelp post-Series A; Allset at Series B), consistent with a fund that reserves capital for follow-ons in its winners.
Check Size
Primary ticket size is €0.5M-€4M, with follow-ons of up to €10M reserved for standout portfolio companies. This is consistent across public fund materials and the firm's own site copy.
Lead Tendency
Mixed - Inovo both leads and co-leads/participates. Recent examples show both patterns: it co-led Banani AI's €850K pre-seed alongside Specialist VC (May 2025), and participated (not lead) in Ingenix.ai's €13M seed extension led by Sofinnova Partners (June 2026), while its earlier €9M Ingenix.ai seed was Inovo-led. Overall lead tendency is best classified as "both."
Recent Activity
Fund III (€107M-€105M depending on source, vintage 2022, final close announced June 2023) is the firm's current active vehicle, one of the four largest funds in the CEE region, targeting 25-30 portfolio companies with backers including IFC (World Bank Group), the European Investment Fund, and Poland's PFR Ventures. As of 2025 reporting, Inovo had deployed into 28 of an expected ~38 companies from Fund III, with roughly 10 more planned. The firm was cited as the most active VC fund in Poland in 2024, closing six new investments that year, and continued deploying into 2025 (Prepia, Banani, mysite.ai among others) and 2026 (participation in Ingenix.ai's seed extension). Fund status reads as actively deploying.
Portfolio Highlights
Inovo's portfolio includes six companies that have crossed €100M+ valuations: Booksy, Infermedica, Packhelp, Preply, Spacelift, and Tidio - a strong marker for a CEE-focused early-stage fund. The first fund is reported to include IPO exits (Brand24, ECC Games) and other realized exits (e.g., Sotrender), with 19 total exits reported across the firm's history. Booksy and Restaumatic remain notable unrealized Fund I positions. The current portfolio spans Poland, Ukraine, Lithuania, Croatia, Serbia, Latvia, Moldova, Romania, Czech Republic, Slovakia, Denmark, and the Netherlands/Belgium, reflecting the pan-CEE-plus-diaspora mandate.
Team
- Tomasz Swieboda - Partner (focus: second-time founders, US market entry, B2B)
- Michał Rokosz - Partner (focus: B2B2C, SME, healthcare)
- Maciej Małysz - Partner (focus: developer tools, DevOps, deeptech, B2B enterprise, infrastructure)
- Karol Lasota - Partner (focus: data science, deeptech, AI; also writes the firm's "Inside Inovo" market commentary)
- Dawid Sugier - Principal (focus: B2B SaaS, marketplaces, consumer, Baltics)
- Zuzanna Kompowska - Analyst (focus: AI, healthcare, consumer)
- Sebastian Czerwiński - Partner & CFO
- Daria Meysztowicz-Matusiak - Legal Counsel
- Michał Scipio del Campo - Investor Relations
- Paulina Motty - Ops & Administration Manager
- Damian Zapłata - Venture Partner
- Ariel Finkelstein - Venture Partner
The partnership is functionally specialized by sector (dev tools/deeptech, data science/AI, healthcare/B2B2C) rather than generalist, with dedicated CFO, legal, IR, and ops roles supporting the investing team - a relatively institutionalized structure for a CEE-focused fund of this size.
Decision Process
Not explicitly disclosed on the website, but the four-partner investing team plus a principal and analyst points to a partnership-style decision process rather than a solo-GP model.
Founder Preferences
Inovo explicitly favors "ambitious founders" pursuing large markets with products that are "10x better than anything else," and is willing to back higher-risk, higher-upside bets over safer, modest-return companies. Its support infrastructure (100+ hires facilitated via a dedicated Head of Talent, 70+ international co-investor relationships, 200+ follow-on introductions, 30+ unicorn customer relationships generating $2M+ in contracts, 20+ advisors, software credit partnerships worth $100K+) signals a preference for founders who will actively use a hands-on platform, particularly around US market expansion and follow-on fundraising.
Geographic Focus
Central and Eastern Europe and diaspora founders specifically: Poland, Lithuania, Croatia, Serbia, Ukraine, Latvia, Estonia, Romania, Bulgaria, Slovenia, Czech Republic, Hungary, Slovakia, North Macedonia, Bosnia, Kosovo, Albania, and Montenegro. The firm is headquartered in Warsaw with additional presence in Amsterdam and Luxembourg, and has an explicit secondary focus on helping portfolio companies expand into the US market.